Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

An application of ABCC3-013 mRNA in preparation of a kit used for detecting clopidogrel resistance and the kit

A technology of clopidogrel resistance and kit, which is applied to the determination/testing of microorganisms, biochemical equipment and methods, and medical preparations containing active ingredients, etc., which can solve the problem that the mechanism of clopidogrel resistance is not very clear and the lack of clopidogrel Gray resistance markers and other issues

Active Publication Date: 2018-01-05
普灵生物(南京)有限公司
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The mechanism of clopidogrel resistance is not very clear, and clinically effective markers of clopidogrel resistance are also lacking

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • An application of ABCC3-013 mRNA in preparation of a kit used for detecting clopidogrel resistance and the kit
  • An application of ABCC3-013 mRNA in preparation of a kit used for detecting clopidogrel resistance and the kit
  • An application of ABCC3-013 mRNA in preparation of a kit used for detecting clopidogrel resistance and the kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Example 1: Application of ABCC3-013 mRNA in the preparation of a kit for detecting clopidogrel resistance.

[0021] 1. A kit for detecting clopidogrel resistance, including the following components:

[0022] TRIZOL reagent,

[0023] Chloroform,

[0024] isopropanol,

[0025] DEPC water,

[0026] Oligo dT primer (Oligo dT primer),

[0027] Random 6-nucleotide primers (Random 6-mers),

[0028] reverse transcriptase (PrimeScript TM RT Enzyme Mix),

[0029] RNase-free water (RNase-free dH 2 O),

[0030] Reverse transcription buffer (PrimeScript TM buffer),

[0031] Taq enzyme, dNTPs, Mg 2+ , SYBR Green I (SYBR Premix Ex Taq TM ),

[0032] ROX Reference Dye, and

[0033] Specific primers SEQ ID NO.5 and SEQ ID NO.6 for ABCC3-013 mRNA (nucleotide sequence shown in SEQ ID NO.2).

[0034] 2. How to use the kit

[0035] The peripheral blood RNA of the patient was extracted, and the content of ABCC3-013 mRNA was detected by qRT-PCR, and the specific operation wa...

Embodiment 2

[0062] Example 2: Experimental research.

[0063] ABCC3-013 mRNA is a non-wild-type mRNA splicing variant of ABCC3 gene due to abnormal mRNA splicing caused by point mutations. In the following experiments, ABCC3-002 mRNA, another splice variant of the ABCC3 gene, was used as a control to examine the biological activity of ABCC3-013 mRNA.

[0064] 1. Cell culture: HepG2 cells were cultured in high-glucose DMEM medium containing 10% inactivated fetal bovine serum, 50 U / ml penicillin and 50 μg / ml streptomycin, at 37°C and 5% CO in saturated humidity 2 Incubator cultivation.

[0065] 2. Plasmid construction.

[0066] Method: ABCC3-002 (SEQ ID NO.1) and ABCC3-013 (SEQ ID NO.2) fragments were chemically synthesized, fragments ABCC3-002-EGFP and ABCC3-013-EGFP containing EGFP were synthesized, and random fragments were synthesized as a control group, the synthetic fragments were cloned into the TV5 vector. The recombinant vectors were named TV5, ABCC3-002, ABCC3-013, TV5-EGFP, A...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an application of ABCC3-013 mRNA in preparation of a kit used for detecting clopidogrel resistance. The nucleotide sequence of the ABCC3-013 mRNA is shown as SEQ ID NO.2. Clopidogrel resistance of a patient can be detected through detecting the expression level of the ABCC3-013 mRNA in the body (for example, peripheral blood) of the patient, thus providing novel methods forassisted clinical treatment, and prognosis and curative effect estimation. The invention also includes the kit for detecting clopidogrel resistance. The kit can be used for detecting clopidogrel resistance of a patient through detecting the expression level of the ABCC3-013 mRNA in the body (for example, peripheral blood) of the patient. Clinical experiments show that the diagnosis sensitivity ofthe kit is 52% and specificity is 86%.

Description

technical field [0001] The invention relates to a kit for detecting drug resistance, in particular to a kit for detecting clopidogrel resistance. Background technique [0002] As an antiplatelet drug, clopidogrel is the most commonly used drug to prevent stent thrombosis after percutaneous coronary intervention (PCI) implantation of stents in patients with coronary heart disease. It is combined with aspirin to form "dual antiplatelet therapy" The regimen is the "gold standard" antiplatelet therapy regimen for acute coronary syndrome and PCI after stent implantation. Clopidogrel resistance (or tolerance) occurs in 10-40% of patients treated with clopidogrel, showing that the antiplatelet effect of clopidogrel does not meet the expected requirements, resulting in poor efficacy of the drug. [0003] The existing platelet aggregation test and thromboelastography can evaluate clopidogrel resistance to a certain extent; however, the repeatability of the platelet aggregation test ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6883
CPCA61K31/7105C12Q1/6883C12Q2600/106C12Q1/68C12Q1/6816C12Q1/6827C12Q1/6832C12Q1/6876
Inventor 谢红光柳伟强潘玉琴杨平殷蒨米琼宇
Owner 普灵生物(南京)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com